The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Market Size Estimates For The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market In 2026 And 2030?
The benign prostatic hyperplasia (bph) treatment devices and equipment market has experienced strong growth in recent years. This market is forecasted to increase from $1.34 billion in 2025 to $1.43 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.3%. The historical expansion of the market can be linked to the rising prevalence of benign prostatic hyperplasia, enhanced awareness of urological disorders, the adoption of transurethral procedures, the expansion of hospital urology departments, and improvements in endoscopic surgical tools.
The benign prostatic hyperplasia (bph) treatment devices and equipment market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $1.86 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This expansion during the forecast period can be attributed to the rising elderly male population, a growing inclination towards minimally invasive treatments, the proliferation of outpatient urology clinics, increased uptake of laser and implant-based treatment modalities, and an intensified emphasis on shorter hospitalizations. Key trends shaping the market over the forecast period encompass a greater embrace of minimally invasive BPH treatment equipment, the escalating utilization of laser-based prostate interventions, an increasing desire for implant-driven treatment solutions, the broadening availability of office-based BPH procedures, and a heightened commitment to patient well-being and recuperation.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp
What Key Drivers Are Fueling The Growth Of The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
The projected increase in prostate cancer diagnoses is set to stimulate the expansion of the benign prostatic hyperplasia market. Prostate cancer is characterized as a malignancy that develops within the prostate gland, a small organ resembling a walnut located directly beneath the bladder in men. A higher prevalence of prostate cancer often leads more older men to consult medical professionals for prostate-related concerns, consequently boosting the identification and management of benign prostatic hyperplasia. For instance, in February 2023, data from the American Society of Clinical Oncology (ASCO), a US-based professional organization that publishes patient information on the cancer.net website, indicated an estimated 288,300 men in the United States had prostate cancer in 2023. Furthermore, in 2022, there were 268,490 new cases and 34,500 deaths from prostate cancer. Thus, the escalating incidence of prostate cancer cases is actively driving the growth of the benign prostatic hyperplasia market.
How Is The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Categorized Across Its Segment Groups?
The benign prostatic hyperplasia (bph) treatment devices and equipment market covered in this report is segmented –
1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types
3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Specialty Urology Centers
Subsegments:
1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes
2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation
3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers
4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents
5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment
What Trends Are Influencing The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
Leading companies in the benign prostatic hyperplasia (BPH) treatment devices and equipment market are increasingly focusing on developing innovative, minimally invasive solutions such as temporarily implantable devices. These solutions aim to broaden access to outpatient treatment and reduce dependence on long-term medication or surgical tissue removal procedures. Temporarily implantable BPH devices are designed for single or short-term use, specifically engineered to reshape the prostatic urethra and alleviate lower urinary tract symptoms (LUTS) caused by an enlarged prostate. For instance, in February 2025, Olympus, a Japan-based medical technology company, announced a significant milestone for its iTind device, with expanded availability across major APAC markets (Thailand, Australia, Hong Kong, Singapore, India, and a planned launch in Korea). Olympus highlighted that the iTind procedure offers a minimally invasive, clinic-room option that can be performed under local anaesthesia and is supported by a comprehensive physician training programme to aid clinical adoption. The iTind itself is a temporarily implantable nitinol device that reshapes the prostatic urethra to improve urinary flow and patient quality of life, with its adoption being accelerated by recent developments in guidelines and reimbursement.
Which Firms Are Influencing Competition In The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
Major companies operating in the benign prostatic hyperplasia (bph) treatment devices and equipment market are Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston Scientific Inc., NeoTract Inc., OmniGuide Inc., ProArc Medical Ltd., Urotech Devices, Prostalund Operations AB, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, PROCEPT BioRobotics, Quanta System
Get The Full Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report:
Which Region Holds The Highest Market Share In The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2025. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (bph) treatment devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=2431&type=smp
Browse Through More Reports Similar to the Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market 2026, By The Business Research Company
Drugs For Benign Prostatic Hypertrophy Market Report 2026
Prostate Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report
Prostate Cancer Nuclear Medicine Diagnostics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model